Cargando…

Hepatotoxicity Secondary to Chemotherapy

The difficult problem faced by multiple generation of practicing physicians is determining the cause of abnormal liver function tests in cancer patients on chemotherapy. Hepatotoxicity from chemotherapy occurs frequently from an unpredictable or idiosyncratic reaction. Despite remarkable advances in...

Descripción completa

Detalles Bibliográficos
Autores principales: Grigorian, Alla, O'Brien, Christopher B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521265/
https://www.ncbi.nlm.nih.gov/pubmed/26357620
http://dx.doi.org/10.14218/JCTH.2014.00011
_version_ 1782383783762198528
author Grigorian, Alla
O'Brien, Christopher B.
author_facet Grigorian, Alla
O'Brien, Christopher B.
author_sort Grigorian, Alla
collection PubMed
description The difficult problem faced by multiple generation of practicing physicians is determining the cause of abnormal liver function tests in cancer patients on chemotherapy. Hepatotoxicity from chemotherapy occurs frequently from an unpredictable or idiosyncratic reaction. Despite remarkable advances in our understanding of the mechanisms of action, pharmacodynamics, and interrelationships between the liver and chemotherapy, the underlying etiology of hepatic toxicity for various agents remains unexplained. Here, we present a concise review of the broad differential diagnosis for abnormal liver function tests (LFTs) in oncology patients.
format Online
Article
Text
id pubmed-4521265
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher XIA & HE Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-45212652015-09-09 Hepatotoxicity Secondary to Chemotherapy Grigorian, Alla O'Brien, Christopher B. J Clin Transl Hepatol Review Article The difficult problem faced by multiple generation of practicing physicians is determining the cause of abnormal liver function tests in cancer patients on chemotherapy. Hepatotoxicity from chemotherapy occurs frequently from an unpredictable or idiosyncratic reaction. Despite remarkable advances in our understanding of the mechanisms of action, pharmacodynamics, and interrelationships between the liver and chemotherapy, the underlying etiology of hepatic toxicity for various agents remains unexplained. Here, we present a concise review of the broad differential diagnosis for abnormal liver function tests (LFTs) in oncology patients. XIA & HE Publishing Ltd 2014-06-15 2014-06 /pmc/articles/PMC4521265/ /pubmed/26357620 http://dx.doi.org/10.14218/JCTH.2014.00011 Text en © 2014 The Second Affiliated Hospital of Chongqing Medical University. Published by XIA & HE Publishing Ltd. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Grigorian, Alla
O'Brien, Christopher B.
Hepatotoxicity Secondary to Chemotherapy
title Hepatotoxicity Secondary to Chemotherapy
title_full Hepatotoxicity Secondary to Chemotherapy
title_fullStr Hepatotoxicity Secondary to Chemotherapy
title_full_unstemmed Hepatotoxicity Secondary to Chemotherapy
title_short Hepatotoxicity Secondary to Chemotherapy
title_sort hepatotoxicity secondary to chemotherapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521265/
https://www.ncbi.nlm.nih.gov/pubmed/26357620
http://dx.doi.org/10.14218/JCTH.2014.00011
work_keys_str_mv AT grigorianalla hepatotoxicitysecondarytochemotherapy
AT obrienchristopherb hepatotoxicitysecondarytochemotherapy